Search Results 311-320 of 15223 for HCG
Female patients who are women of childbearing potential (WCBP) must have a negative pregnancy test (serum-human chorionic gonadotropin (hCG) or urine-hCG ...
If female, pregnancy (defined as positive beta-human chorionic gonadotrophin [Beta-HCG] blood test) or lactating or breast-feeding. Any medical disorders ...
... hCG laboratory test (> 10 mIU/mL); Patients under chronic treatment with systemic corticosteroids or other immunosuppressive drugs for a period of at least 4 ...
The OPTIMUM registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary ...
Serum creatinine ≤ 2.0 mg/dL. Negative serum β-hCG pregnancy test within 72 hours of day 1 of treatment with ABVD in women of child-bearing potential ...
Sexually active WOCBP must be using a medically acceptable method of birth control and have a negative quantitative serum β-HCG test collected at the initial ...
Hextend® injection is used to treat low blood volume (hypovolemia) when other treatment is not available. This medicine is to be given only by or under the ...
Participant, if female, must have a negative serum pregnancy test (beta human chorionic gonadotropin [β-hCG]) at Screening and a negative urine pregnancy test ...
... [hCG]) within 24 hours prior to the start of study therapy. Women must not be breastfeeding. Men who are sexually active with WOCBP must use any ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.